1. Anthropic stock drops as a key support disappears
Anthropic stock fell about 11% on Friday, November 20, after the AI company said its underwriters had exercised their over-allotment option in full, buying 147 million additional shares at the $83 offering price. The move, known as exercising the greenshoe, removed the mechanism that Morgan Stanley, the deal's stabilization agent, could otherwise have used to buy shares in the market and support the price.
The timing was awkward. The potential buyer of last resort effectively stepped back just as selling pressure built, and the slide left the shares in the mid-$80s, still above the price at which the offering was sold but with far less of a cushion than they enjoyed on their first day of trading.
The decline came during a broader pullback in AI and technology stocks, suggesting that sentiment across the sector, and not only factors specific to Anthropic, played a part in Friday's move.
2. From an $83 pricing to a $111.50 open
Anthropic priced its initial public offering at $83 per share on November 18 and began trading on Nasdaq the following day under the ticker ANT.
Demand at the open was strong. The shares started trading at $111.50, roughly 34% above the offering price, before giving back part of that gain during the session. They closed Thursday at $97.17, about 17% above the $83 price.
Friday told a different story. The stock was already down by more than 10% in premarket trading and finished the session's slide around 11% lower, a sharp reversal for a listing that had drawn heavy interest from institutional and individual investors alike.
Even after the drop, Anthropic shares remained above the IPO price. But the margin over $83 had narrowed considerably compared with where it stood just one day earlier, putting that level squarely in focus for traders.
3. What is a greenshoe option?
A greenshoe, formally called an over-allotment option, gives the banks underwriting an IPO the right to buy extra shares from the issuing company at the offering price, usually within 30 days of the listing. It works as a kind of shock absorber for a new stock, giving underwriters flexibility to handle surplus demand and early price swings.
The mechanics run as follows. When the deal is launched, the underwriters sell more shares to investors than the base offering contains, creating a short position. What happens next depends on how the stock trades.
If the shares fall below the offering price, the stabilization agent can buy stock in the open market to close that short position. That buying props up the price at a moment when it would otherwise be under pressure. If the shares trade comfortably above the offering price, buying in the market would be costly, so the underwriters instead close the short by purchasing the extra shares from the company at the IPO price through the option.
In Anthropic's case, the prospectus gave the underwriters 30 days to acquire up to 147 million additional Class A shares at the offering price. They took the second route and used the full option after only one day, which is the standard choice when a new listing is trading well above its offering price.
4. Why is Anthropic stock down?
Anthropic stock is down mainly because exercising the full greenshoe closed out the short position that would have let Morgan Stanley buy shares to support the price, and the news arrived during a wider selloff in AI and technology stocks.
Once the option is fully exercised, the underwriters' short position is covered with newly issued shares from the company. That leaves the stabilizing bank with no remaining short to cover through open-market purchases, and so no built-in reason to step in as a buyer if the shares fall.
The practical effect is that ANT now trades on ordinary supply and demand, a process often described as price discovery. For many investors in a new listing, the knowledge that a stabilizing bank stands ready to buy acts as a psychological floor. With the greenshoe used up, that floor is gone.
There is one caveat. Morgan Stanley remains the stabilization agent on paper, and exercising the greenshoe did not eliminate the underwriters' general ability to buy shares. What it removed was the most important and commonly used source of stabilizing demand in the weeks after an IPO.
5. Why banks build stabilization into big IPOs
Stabilization exists because the first days of trading in a new stock are unusually fragile. Before a listing, there is no market price, only the offering price that the company and its bankers agreed on after gauging investor demand. Once trading starts, that estimate is tested in real time by buyers and sellers who may have very different views.
For a very large offering, the risk is magnified. A deal of Anthropic's size puts an enormous number of shares into the hands of new owners at once, and some of them may want to sell quickly, whether to lock in a first-day gain or because they received a larger allocation than they wanted to keep. Without any support, that early selling could push the price down sharply and damage confidence in the listing.
The greenshoe gives the lead bank a tool to dampen that kind of slide in the weeks after a debut. It also protects the underwriters themselves: because they can cover their short position either in the market or through the option, they are not forced into losses whichever way the stock moves.
The tool is designed to defend the price when a stock trades below its offering level. When a listing opens strongly, as Anthropic's did, the logic of the option points toward exercising it and taking the extra shares from the company. The trade-off is the one Anthropic's shareholders experienced on Friday: once that choice is made, the support it could have provided is no longer available.
6. A record offering grows to $119.5 billion
Exercising the option enlarged a deal that was already a record. With the 147 million additional shares, the offering grew to about 1.127 billion shares, and gross proceeds from the IPO rose to roughly $93.5 billion.
The arithmetic is straightforward: 147 million shares at $83 each adds about $12.2 billion to the roughly $81.3 billion raised at pricing.
Alongside the public offering, Anthropic arranged a $26 billion private placement. Taken together, Anthropic and its selling co-founders have raised about $119.5 billion, up from $107.3 billion at the time of pricing.
The company's share of that money is secured regardless of how the shares trade from day to day. For a company whose business depends on training ever larger AI models and building out the computing infrastructure to run them, the capital raised through the IPO and placement provides a substantial reserve for model development, data centers and expansion.
7. What the $83 level means for investors
For traders, the $83 offering price has become the reference point to watch. A new listing that falls below its IPO price is said to have 'broken issue', which is often read as a signal that demand at the offering was overestimated and can weigh on sentiment toward the stock for some time.
With shares in the mid-$80s after Friday's decline, Anthropic was trading only a few dollars above that line. Without the stabilization agent's greenshoe position as a backstop, how the stock behaves around that level will depend on ordinary buying and selling.
The context matters too. Friday's move coincided with weakness across AI and technology shares, so part of the pressure on Anthropic reflects the mood of the sector rather than any new information about the company's business. Investors weighing the stock are likely to watch whether that broader pullback continues or eases.
It is also worth separating the stock price from the company's finances. A falling share price affects investors who bought in, but it does not reduce the money Anthropic has already collected from the offering and the private placement.
8. What comes next for Anthropic shares
With the greenshoe fully exercised one day into trading, the most commonly watched source of post-IPO support is no longer in play. The next phase for Anthropic stock will be shaped by the direction of the wider AI and technology trade and by how investors value the company now that the excitement of its debut has faded.
Investors will also be watching for any further moves by the underwriters, since Morgan Stanley's formal role as stabilization agent continues even though the greenshoe has been used. In practice, though, the absence of a short position to cover means the market, not the bank, will set the tone.
The $83 offering price is the level traders are most likely to focus on in the coming sessions. Whether ANT holds above it, or slips below, will be read as an early verdict on how the market values one of the largest stock offerings on record.
For Anthropic itself, the day-to-day swings in its share price do not change the size of the war chest it has assembled. The capital raised through the IPO and the $26 billion private placement remains in place, giving the company resources to pursue its plans whatever the stock does in its first weeks as a public company. The share price will matter for investor sentiment, employee equity and the company's standing in the market, but it does not claw back money already raised.
